BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
Moodys
Fuji
Novartis
QuintilesIMS
Queensland Health
Teva
Chinese Patent Office
Argus Health
Johnson and Johnson

Generated: January 17, 2018

DrugPatentWatch Database Preview

Details for Patent: 3,886,277

« Back to Dashboard

Summary for Patent: 3,886,277
Title: Methods of controlling dandruff using 5,7-dichloro-8-hydroxy quinoline
Abstract:A method and composition for controlling dandruff on the human scalp using 5,7-dichlor-8-hydroxy quinoline or a salt thereof.
Inventor(s): Randebrock; Rudolf (Hamburg-Othmarschen, DT), Bollert; Volker (Hamburg, DT), Lukesch; Heinz (Hamburg-Sasel, DT), Muller; Gertrud (Hamburg, DT), Rappen; Ludwig (Diusburg-Meiderich, DT), Galle; Friedhelm (Duisberg-Hamborn, DT)
Assignee: Hans Schwarzkopf GmbH (Hamburg, DT)
Application Number:05/359,046
Patent Claim Types:
see list of patent claims
Use; Composition;

Drugs Protected by US Patent 3,886,277

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 3,886,277

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
40231Feb 14, 1967

International Patents Family Members for US Patent 3,886,277

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 297940 ➤ Subscribe
Belgium 710394 ➤ Subscribe
Switzerland 495749 ➤ Subscribe
Germany 1617836 ➤ Subscribe
Denmark 124586 ➤ Subscribe
Finland 47841 ➤ Subscribe
France 1574716 ➤ Subscribe
United Kingdom 1209848 ➤ Subscribe
Italy 983061 ➤ Subscribe
Netherlands 6801267 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Cipla
Queensland Health
Federal Trade Commission
Argus Health
Covington
Julphar
Express Scripts
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot